Showing results (111-120 of 463) with videos related to
Sort By:
Pageof 47
Clinical Pharmacology and Therapeutics|May 1, 1999
The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetronK Villikka, K T Kivistö, P J NeuvonenEuropean Journal of Clinical Pharmacology|October 26, 2000
Grapefruit juice can increase the plasma concentrations of oral methylprednisoloneT Varis, K T Kivistö, P J NeuvonenPharmacology & Toxicology|April 1, 1995
Interaction between erythromycin and nitrazepam in healthy volunteersH Luurila, K T Olkkola, P J NeuvonenEuropean Journal of Clinical Pharmacology|January 1, 1981
Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agentP J Pentikäinen, P J Neuvonen, C BackmanInternational Journal of Clinical Pharmacology and Biopharmacy|June 1, 1978
Assessment of beta-blocking activity of trimepranol in manP J Pentikäinen, P J Neuvonen, A PenttiläClinical Pharmacology and Therapeutics|December 1, 1994
Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazoleA Varhe, K T Olkkola, P J NeuvonenEuropean Journal of Clinical Pharmacology|June 29, 2005
Effects of orange juice on the pharmacokinetics of atenololJ J Lilja, K Raaska, P J NeuvonenEuropean Journal of Clinical Pharmacology|September 1, 1979
Pharmacokinetics of metformin after intravenous and oral administration to manP J Pentikäinen, P J Neuvonen, A PenttiläInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1987
Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseasesE Tiula, L G Tallgren, P J NeuvonenInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1987
Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseasesE Tiula, E J Haapanen, P J NeuvonenPageof 47